Kiadis Pharma N.V.
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
28 oct 2015 - 12:00
Statutory name
Kiadis Pharma N.V.
Title
Kiadis Pharma notice of meeting of shareholders
Comments
Amsterdam, The Netherlands, October 28, 2015 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments for blood cancers and inherited blood disorders, today announces that it will hold an extraordinary general meeting of shareholders on December 9, 2015 at 14:00 CET at the Amsterdam Stock Exchange (Euronext), Beursplein 5, 1012 JW Amsterdam, The Netherlands.
Date last update: 23 April 2026